Literature DB >> 19754476

Decreased serum lipids in patients with probable Alzheimer's disease.

Orhan Lepara1, Amina Valjevac, Azra Alajbegović, Asija Zaćiragić, Emina Nakas-Ićindić.   

Abstract

Alzheimer;s disease (AD) is a multifactorial disease but its aetiology and pathophisiology are still not fully understood. Epidemiologic studies examining the association between lipids and dementia have reported conflicting results. High total cholesterol has been associated with both an increased, and decreased, risk of AD and/or vascular dementia (VAD), whereas other studies found no association. The aim of this study was to investigate the serum lipids concentration in patients with probable AD, as well as possible correlation between serum lipids concentrations and cognitive impairment. Our cross-sectional study included 30 patients with probable AD and 30 age and sex matched control subjects. The probable AD was clinically diagnosed by NINCDS-ADRDA criteria. Serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG) levels were determined at the initial assessment using standard enzymatic colorimetric techniques. Low-density lipoprotein cholesterol (LDL-C) and very low density lipoprotein cholesterol (VLDL-C) levels were calculated. Subjects with probable AD had significantly lower serum TG (p<0,01), TC (p<0,05), LDL-C (p<0,05) and VLDL-C (p<0,01) compared to the control group. We did not observe significant difference in HDL-C level between patients with probable AD and control subjects. Negative, although not significant correlation between TG, TC and VLDL-C and MMSE in patients with AD was observed. In the control group of subjects there was a negative correlation between TC and MMSE but it was not statistically significant (r = -0,28). Further studies are required to explore the possibility for serum lipids to serve as diagnostic and therapeutic markers of AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19754476      PMCID: PMC5632505          DOI: 10.17305/bjbms.2009.2809

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  31 in total

1.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

2.  Serum cholesterol and risk of Alzheimer disease: a community-based cohort study.

Authors:  G Li; J B Shofer; W A Kukull; E R Peskind; D W Tsuang; J C S Breitner; W McCormick; J D Bowen; L Teri; G D Schellenberg; E B Larson
Journal:  Neurology       Date:  2005-10-11       Impact factor: 9.910

3.  APOE genotype, plasma lipids, lipoproteins, and AD in community elderly.

Authors:  S N Romas; M X Tang; L Berglund; R Mayeux
Journal:  Neurology       Date:  1999-08-11       Impact factor: 9.910

4.  Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease.

Authors:  I L Notkola; R Sulkava; J Pekkanen; T Erkinjuntti; C Ehnholm; P Kivinen; J Tuomilehto; A Nissinen
Journal:  Neuroepidemiology       Date:  1998       Impact factor: 3.282

5.  Cholesterol and neuropathologic markers of AD: a population-based autopsy study.

Authors:  L J Launer; L R White; H Petrovitch; G W Ross; J D Curb
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

6.  High total cholesterol levels in late life associated with a reduced risk of dementia.

Authors:  M M Mielke; P P Zandi; M Sjögren; D Gustafson; S Ostling; B Steen; I Skoog
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

7.  Characterization of the lipid profile in dementia and depression in the elderly.

Authors:  Nikolaos Dimopoulos; Christina Piperi; Aristea Salonicioti; Vassiliki Psarra; Charalampos Mitsonis; Ioannis Liappas; Robert W Lea; Anastasios Kalofoutis
Journal:  J Geriatr Psychiatry Neurol       Date:  2007-09       Impact factor: 2.680

8.  Lower serum triglyceride level is associated with increased stroke severity.

Authors:  Tomasz Dziedzic; Agnieszka Slowik; Elzbieta A Gryz; Andrzej Szczudlik
Journal:  Stroke       Date:  2004-05-06       Impact factor: 7.914

9.  Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study.

Authors:  J Kuusisto; K Koivisto; L Mykkänen; E L Helkala; M Vanhanen; T Hänninen; K Kervinen; Y A Kesäniemi; P J Riekkinen; M Laakso
Journal:  BMJ       Date:  1997-10-25

10.  Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.

Authors:  Zaldy Sy Tan; Sudha Seshadri; Alexa Beiser; Peter W F Wilson; Douglas P Kiel; Michael Tocco; Ralph B D'Agostino; Philip A Wolf
Journal:  Arch Intern Med       Date:  2003-05-12
View more
  15 in total

1.  High normal plasma triglycerides are associated with preserved cognitive function in Chinese oldest-old.

Authors:  Zhao-Xue Yin; Xiao-Ming Shi; Virginia B Kraus; Simon M Fitzgerald; Han-Zhu Qian; Jian-Wei Xu; Yi Zhai; Melanie D Sereny; Yi Zeng
Journal:  Age Ageing       Date:  2012-03-23       Impact factor: 10.668

2.  The expression of inflammatory cytokines on the aorta endothelia are up-regulated in pinealectomized rats.

Authors:  Yu Wang; Xiaoyan Liu; Wei Wang; Wei Song; Lianfeng Chen; Quan Fang; Xiaowei Yan
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

3.  Triglycerides are negatively correlated with cognitive function in nondemented aging adults.

Authors:  Vishnu Parthasarathy; Darvis T Frazier; Brianne M Bettcher; Laura Jastrzab; Linda Chao; Bruce Reed; Dan Mungas; Michael Weiner; Charles DeCarli; Helena Chui; Joel H Kramer
Journal:  Neuropsychology       Date:  2017-06-12       Impact factor: 3.295

4.  Plasma Leptin Reflects Progression of Neurofibrillary Pathology in Animal Model of Tauopathy.

Authors:  Martin Cente; Stefan Zorad; Tomas Smolek; Lubica Fialova; Natalia Paulenka Ivanovova; Katarina Krskova; Lucia Balazova; Rostislav Skrabana; Peter Filipcik
Journal:  Cell Mol Neurobiol       Date:  2020-09-30       Impact factor: 5.046

5.  Longitudinal trajectories of cholesterol from midlife through late life according to apolipoprotein E allele status.

Authors:  Brian Downer; Steven Estus; Yuriko Katsumata; David W Fardo
Journal:  Int J Environ Res Public Health       Date:  2014-10-16       Impact factor: 4.614

6.  Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men.

Authors:  Cheng Ma; Jin Li; Zhijun Bao; Qingwei Ruan; Zhuowei Yu
Journal:  Biomed Res Int       Date:  2015-11-23       Impact factor: 3.411

7.  Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: a case-control study.

Authors:  Qian He; Qing Li; Jiangang Zhao; Tianfeng Wu; Lu Ji; Guowei Huang; Fei Ma
Journal:  Lipids Health Dis       Date:  2016-09-05       Impact factor: 3.876

Review 8.  The Role of High Triglycerides Level in Predicting Cognitive Impairment: A Review of Current Evidence.

Authors:  Alina Mihaela Dimache; Delia Lidia Șalaru; Radu Sascău; Cristian Stătescu
Journal:  Nutrients       Date:  2021-06-20       Impact factor: 5.717

9.  Serum triglycerides in Alzheimer disease: Relation to neuroimaging and CSF biomarkers.

Authors:  Megan M Bernath; Sudeepa Bhattacharyya; Kwangsik Nho; Dinesh Kumar Barupal; Oliver Fiehn; Rebecca Baillie; Shannon L Risacher; Matthias Arnold; Tanner Jacobson; John Q Trojanowski; Leslie M Shaw; Michael W Weiner; P Murali Doraiswamy; Rima Kaddurah-Daouk; Andrew J Saykin
Journal:  Neurology       Date:  2020-05-01       Impact factor: 11.800

Review 10.  Effects of Plasma Lipids and Statins on Cognitive Function.

Authors:  Rui Li; Tian-Jun Wang; Pei-Yuan Lyu; Yang Liu; Wei-Hong Chen; Ming-Yue Fan; Jing Xu
Journal:  Chin Med J (Engl)       Date:  2018-02-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.